FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
215192NDAAKEBIA001VAFSEOTABLET;ORAL150MGVADADUSTAT2024-03-27PrescriptionNo
002VAFSEOTABLET;ORAL300MGVADADUSTAT2024-03-27PrescriptionNo
003VAFSEOTABLET;ORAL450MGVADADUSTAT2024-03-27PrescriptionYes